351 related articles for article (PubMed ID: 17559367)
1. Norfloxacin and trimethoprim-sulfamethoxazole therapy have similar efficacy in prevention of spontaneous bacterial peritonitis.
Lontos S; Gow PJ; Vaughan RB; Angus PW
J Gastroenterol Hepatol; 2008 Feb; 23(2):252-5. PubMed ID: 17559367
[TBL] [Abstract][Full Text] [Related]
2. Continuous versus inpatient prophylaxis of the first episode of spontaneous bacterial peritonitis with norfloxacin.
Novella M; Solà R; Soriano G; Andreu M; Gana J; Ortiz J; Coll S; Sàbat M; Vila MC; Guarner C; Vilardell F
Hepatology; 1997 Mar; 25(3):532-6. PubMed ID: 9049193
[TBL] [Abstract][Full Text] [Related]
3. A randomized controlled study of trimethoprim-sulfamethoxazole versus norfloxacin for the prevention of infection in cirrhotic patients.
Lontos S; Shelton E; Angus PW; Vaughan R; Roberts SK; Gordon A; Gow PJ
J Dig Dis; 2014 May; 15(5):260-7. PubMed ID: 24612987
[TBL] [Abstract][Full Text] [Related]
4. Addition of probiotics to norfloxacin does not improve efficacy in the prevention of spontaneous bacterial peritonitis: a double-blind placebo-controlled randomized-controlled trial.
Pande C; Kumar A; Sarin SK
Eur J Gastroenterol Hepatol; 2012 Jul; 24(7):831-9. PubMed ID: 22522141
[TBL] [Abstract][Full Text] [Related]
5. Norfloxacin vs ceftriaxone in the prophylaxis of infections in patients with advanced cirrhosis and hemorrhage.
Fernández J; Ruiz del Arbol L; Gómez C; Durandez R; Serradilla R; Guarner C; Planas R; Arroyo V; Navasa M
Gastroenterology; 2006 Oct; 131(4):1049-56; quiz 1285. PubMed ID: 17030175
[TBL] [Abstract][Full Text] [Related]
6. Parenteral antibiotic prophylaxis of bacterial infections does not improve cost-efficacy of oral norfloxacin in cirrhotic patients with gastrointestinal bleeding.
Sàbat M; Kolle L; Soriano G; Ortiz J; Pamplona J; Novella MT; Villanueva C; Sainz S; Torras J; Balanzó J; Guarner C
Am J Gastroenterol; 1998 Dec; 93(12):2457-62. PubMed ID: 9860409
[TBL] [Abstract][Full Text] [Related]
7. Infections caused by Escherichia coli resistant to norfloxacin in hospitalized cirrhotic patients.
Ortiz J; Vila MC; Soriano G; Miñana J; Gana J; Mirelis B; Novella MT; Coll S; Sábat M; Andreu M; Prats G; Solá R; Guarner C
Hepatology; 1999 Apr; 29(4):1064-9. PubMed ID: 10094947
[TBL] [Abstract][Full Text] [Related]
8. Clinical significance of spontaneous Aeromonas bacterial peritonitis in cirrhotic patients: a matched case-control study.
Choi JP; Lee SO; Kwon HH; Kwak YG; Choi SH; Lim SK; Kim MN; Jeong JY; Choi SH; Woo JH; Kim YS
Clin Infect Dis; 2008 Jul; 47(1):66-72. PubMed ID: 18484880
[TBL] [Abstract][Full Text] [Related]
9. Clinical significance and outcome of nosocomial acquisition of spontaneous bacterial peritonitis in patients with liver cirrhosis.
Cheong HS; Kang CI; Lee JA; Moon SY; Joung MK; Chung DR; Koh KC; Lee NY; Song JH; Peck KR
Clin Infect Dis; 2009 May; 48(9):1230-6. PubMed ID: 19302016
[TBL] [Abstract][Full Text] [Related]
10. Randomized-controlled trial of rifaximin versus norfloxacin for secondary prophylaxis of spontaneous bacterial peritonitis.
Elfert A; Abo Ali L; Soliman S; Ibrahim S; Abd-Elsalam S
Eur J Gastroenterol Hepatol; 2016 Dec; 28(12):1450-1454. PubMed ID: 27512927
[TBL] [Abstract][Full Text] [Related]
11. Trimethoprim-sulfamethoxazole versus norfloxacin in the prophylaxis of spontaneous bacterial peritonitis in cirrhosis.
Alvarez RF; Mattos AA; Corrêa EB; Cotrim HP; Nascimento TV
Arq Gastroenterol; 2005; 42(4):256-62. PubMed ID: 16444382
[TBL] [Abstract][Full Text] [Related]
12. Ciprofloxacin in primary prophylaxis of spontaneous bacterial peritonitis: a randomized, placebo-controlled study.
Terg R; Fassio E; Guevara M; Cartier M; Longo C; Lucero R; Landeira C; Romero G; Dominguez N; Muñoz A; Levi D; Miguez C; Abecasis R
J Hepatol; 2008 May; 48(5):774-9. PubMed ID: 18316137
[TBL] [Abstract][Full Text] [Related]
13. [Primary prophylaxis of spontaneous bacterial peritonitis].
Soriano G; Guarner C
Gastroenterol Hepatol; 1997; 20(6):312-4. PubMed ID: 9296848
[No Abstract] [Full Text] [Related]
14. [Development of Escherichia coli strands resistant to quinolones in stools of patients with liver cirrhosis submitted to selective bowel decontamination].
Aparicio JR; Such J; Gutiérrez A; Pérez-Mateo M; Plaza J; Arroyo A
Med Clin (Barc); 1999 Sep; 113(7):241-5. PubMed ID: 10544377
[TBL] [Abstract][Full Text] [Related]
15. Long-term clinical outcome of large volume paracentesis with intravenous albumin in patients with spontaneous bacterial peritonitis: a randomized prospective study.
Choi CH; Ahn SH; Kim DY; Lee SK; Park JY; Chon CY; Moon YM; Han KH
J Gastroenterol Hepatol; 2005 Aug; 20(8):1215-22. PubMed ID: 16048569
[TBL] [Abstract][Full Text] [Related]
16. Long-lasting NO overproduction in cirrhotic patients with spontaneous bacterial peritonitis.
Bories PN; Campillo B; Azaou L; Scherman E
Hepatology; 1997 Jun; 25(6):1328-33. PubMed ID: 9185747
[TBL] [Abstract][Full Text] [Related]
17. Association of proton pump inhibitor therapy with spontaneous bacterial peritonitis in cirrhotic patients with ascites.
Bajaj JS; Zadvornova Y; Heuman DM; Hafeezullah M; Hoffmann RG; Sanyal AJ; Saeian K
Am J Gastroenterol; 2009 May; 104(5):1130-4. PubMed ID: 19337238
[TBL] [Abstract][Full Text] [Related]
18. Norfloxacin modulates the inflammatory response and directly affects neutrophils in patients with decompensated cirrhosis.
Zapater P; Caño R; Llanos L; Ruiz-Alcaraz AJ; Pascual S; Barquero C; Moreu R; Bellot P; Horga JF; Muñoz C; Pérez J; García-Peñarrubia P; Pérez-Mateo M; Such J; Francés R
Gastroenterology; 2009 Nov; 137(5):1669-79.e1. PubMed ID: 19660462
[TBL] [Abstract][Full Text] [Related]
19. Role of host and bacterial virulence factors in Escherichia coli spontaneous bacterial peritonitis.
Cereto F; Herranz X; Moreno E; Andreu A; Vergara M; Fontanals D; Roget M; Simó M; González A; Prats G; Genescà J
Eur J Gastroenterol Hepatol; 2008 Sep; 20(9):924-9. PubMed ID: 18794608
[TBL] [Abstract][Full Text] [Related]
20. A cost analysis of long term antibiotic prophylaxis for spontaneous bacterial peritonitis in cirrhosis.
Das A
Am J Gastroenterol; 1998 Oct; 93(10):1895-900. PubMed ID: 9772051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
